Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitor-Reference-Cited by-同舟云学术

Discovery of imidazo[1,2-a]pyridine-thiophene derivatives as FLT3 and FLT3 mutants inhibitors for acute myeloid leukemia through structure-based optimization of an NEK2 inhibitor

Published:2021-12 Issue: Volume:225 Page:113776
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhang Lingtian,Lakkaniga Naga Rajiv^ORCID,Bharate Jaideep B.^ORCID,Mcconnell Nicholas,Wang Xiuqi,Kharbanda Anupreet,Leung Yuet-Kin,Frett Brendan,Shah Neil P.,Li Hong-yu^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference30 articles.

1. The roles of FLT3 in hematopoiesis and leukemia;Gilliland;Blood,2002

2. Structural and functional alterations of FLT3 in acute myeloid leukemia;Meshinchi;Clin. Canc. Res.,2009

3. The structural basis for autoinhibition of FLT3 by the juxtamembrane domain;Griffith;Mol. Cell,2004

4. FLT3 inhibitors in acute myeloid leukemia: current status and future directions;Larrosa-Garcia;Mol. Canc. Therapeut.,2017

5. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia;Smith;Nature,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy;Critical Reviews in Oncology/Hematology;2024-09

2. N-(3-Methoxyphenyl)-6-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-2-amine is an inhibitor of the FLT3-ITD and BCR-ABL pathways, and potently inhibits FLT3-ITD/D835Y and FLT3-ITD/F691L secondary mutants;Bioorganic Chemistry;2024-02

3. Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma;Molecular Cancer Therapeutics;2024-01-19

4. An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L;European Journal of Medicinal Chemistry;2024-01

5. Pyrazolopyridine-based kinase inhibitors for anti-cancer targeted therapy;RSC Medicinal Chemistry;2024